investor ironwoodpharma.com

Ironwood Pharmaceuticals, Inc. - Investor Relations

At Ironwood, were focused on delivering differentiated medicines to patients. If we do this efficiently and effectively, we hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company. These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders. NASDAQ IRWD 15.43 0.23. Volume 942,811 Change 1.513. Feb 22, 2018.
traffic

OVERVIEW

The domain investor.ironwoodpharma.com presently has an average traffic classification of zero (the lower the more users). We have crawled twenty pages within the web site investor.ironwoodpharma.com and found eighty-two websites associating themselves with investor.ironwoodpharma.com. There are four mass web sites belong to this website.
Pages Parsed
20
Links to this site
82
Social Links
4

INVESTOR.IRONWOODPHARMA.COM TRAFFIC

The domain investor.ironwoodpharma.com is seeing alternating levels of traffic all over the year.
Traffic for investor.ironwoodpharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.ironwoodpharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.ironwoodpharma.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO INVESTOR.IRONWOODPHARMA.COM

Ironwood Pharmaceuticals

You are now leaving ironwoodpharma. You are now leaving ironwoodpharma. This link will take you to. A website to which our privacy policy. Responsible for your interactions with that website. THE ART AND SCIENCE OF MAKING MEDICINES.

Ironwood Pharmaceuticals News Center

You are now leaving ironwoodpharma. This link will take you to. A website to which our privacy policy. Responsible for your interactions with that website. Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973.

WHAT DOES INVESTOR.IRONWOODPHARMA.COM LOOK LIKE?

Desktop Screenshot of investor.ironwoodpharma.com Mobile Screenshot of investor.ironwoodpharma.com Tablet Screenshot of investor.ironwoodpharma.com

INVESTOR.IRONWOODPHARMA.COM SERVER

We found that a single root page on investor.ironwoodpharma.com took four hundred and eighty-three milliseconds to come up. We could not detect a SSL certificate, so therefore our parsers consider this site not secure.
Load time
0.483 sec
SSL
NOT SECURE
IP
206.200.251.19

FAVICON

SITE TITLE

Ironwood Pharmaceuticals, Inc. - Investor Relations

DESCRIPTION

At Ironwood, were focused on delivering differentiated medicines to patients. If we do this efficiently and effectively, we hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company. These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders. NASDAQ IRWD 15.43 0.23. Volume 942,811 Change 1.513. Feb 22, 2018.

PARSED CONTENT

The domain has the following in the web page, "At Ironwood, were focused on delivering differentiated medicines to patients." I observed that the web site also stated " If we do this efficiently and effectively, we hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company." They also stated " These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders. Volume 942,811 Change 1."

SEE OTHER BUSINESSES

Investor Overview - ITC Holdings Corp.

Direct Stock Purchase and Dividend Reinvestment Plan. Michigan Electric Transmission Company, ITC Midwest and ITC Great Plains. Raquo; Latest Proxy Statement. Raquo; 2014 Online Annual Report. Raquo; 2014 Annual Report. Raquo; Investor Fact Sheet. ITC Reports Continued Strong Growth for Second Quarter and Year-to-Date 2015 Results.

investor relations InnerWorkings, Inc.

This website uses cookies to enhance your experience. By continuing to browse the site, you agree to our use of cookies. Retail environments, displays digital POS. InnerWorkings Announces Fourth Quarter and Full-Year 2017 Results. InnerWorkings Announces Select Preliminary Fourth Quarter and Full-Year 2017 Results; Issues 2018 Guidance.

Overview j2 Global

Laquo; Back to Homepage. J2 Global Fourth Quarter 2017 Investor Presentation. J2 Global Fourth Quarter 2017 Investor Presentation. Campaigner Launches Landing Pages to Help Marketers Take Customer Engagement One Click Further.

Jazz Pharmaceuticals - Investor Media - Investors and Media

Q2 2015 Jazz Pharmaceuticals Earnings Conference Call. Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results. Jazz Pharmaceuticals to Report 2015 Second Quarter Financial Results on August 5, 2015.

JetBlue Investor Relations

JetBlue Airways Reports February Traffic. Sign up for email alerts. Keep informed with all our latest investor updates. Enter your email address to sign up for alerts. Please retype info into highlighted field.